"10.1371_journal.pone.0045231","plos one","2012-10-24T00:00:00Z","Deborah Watson-Jones; Keith Tomlin; Pieter Remes; Kathy Baisley; Riziki Ponsiano; Selephina Soteli; Silvia de Sanjosé; John Changalucha; Saidi Kapiga; Richard J Hayes","London School of Hygiene and Tropical Medicine, London, United Kingdom; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania; Medical Research Council Social & Public Health Sciences Unit, Glasgow, United Kingdom; Unit of Infections and Cancer, Cancer Epidemiology Research Programme, lInstitut dInvestigació Biomèdica de Bellvitge, Institut Català dOncologia, Barcelona, Spain; CIBER Epidemiologia, y Salud Publica, Barcelona, Spain; The National Institute for Medical Research, Mwanza, Tanzania","Conceived and designed the experiments: DWJ RH JC. Performed the experiments: DWJ RP PR SS. Analyzed the data: KT KB. Wrote the first draft of the manuscript: DWJ. Contributed to the writing of the manuscript: KT KB JC PR SS SdS SK RH. ICMJE criteria for authorship read and met: DWJ KT KB JC PR SS SdS SK RH. Agree with manuscript results and conclusions: DWJ KT KB JC PR SS SdS SK RH. Enrolled patients: DWJ PR RP.","Deborah Watson-Jones has received grant support through the London School of Hygiene & Tropical Medicine from GSK Biologicals for a phase IIIb safety and immunogenicity trial of the bivalent HPV vaccine. Deborah Watson-Jones and John Changalucha received a donation of the quadrivalent HPV vaccine from Axios through Healthcare Development‚s GARDASIL® Access Program for the study presented in this manuscript.","2012","10","Deborah Watson-Jones","DWJ",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
